Saquinavir labels and packages: Difference between revisions
No edit summary |
|||
| (2 intermediate revisions by the same user not shown) | |||
| Line 4: | Line 4: | ||
==Labels And Packages== | ==Labels And Packages== | ||
= | |||
===PRINCIPAL DISPLAY PANEL - 500 mg Bottle Label=== | |||
NDC 0004-0244-51 | NDC 0004-0244-51 | ||
| Line 19: | Line 19: | ||
Rx only | Rx only | ||
ALERT: Find out about medicines that | '''ALERT: Find out about medicines that | ||
should NOT be taken with INVIRASE. | should NOT be taken with INVIRASE.''' | ||
Attention Pharmacist: Dispense the attached | Attention Pharmacist: Dispense the attached | ||
| Line 27: | Line 27: | ||
120 tablets | 120 tablets | ||
Genentech | |||
{| | |||
|- | |||
| [[File:|800px|thumb]] | |||
|- | |||
|} | |||
===PRINCIPAL DISPLAY PANEL - 200 mg Bottle Label=== | |||
NDC 0004-0245-15 | |||
Invirase® | |||
(saquinavir mesylate) | |||
Capsules | |||
200 mg | |||
Each capsule contains saquinavir | |||
mesylate equivalent to 200 mg | |||
saquinavir (free base). | |||
Rx only | |||
'''ALERT: Find out about | |||
medicines that should NOT be | |||
taken with INVIRASE.''' | |||
Attention Pharmacist: Dispense | |||
the attached Medication Guide to | |||
each patient. Do not cover ALERT | |||
box with pharmacy label. | |||
270 capsules | |||
Genentech<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = INVIRASE (SAQUINAVIR MESYLATE) CAPSULE INVIRASE (SAQUINAVIR MESYLATE) TABLET, FILM COATED [GENENTECH, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c00d1607-ac36-457b-a34b-75ad74f9cf0a | publisher = | date = | accessdate = }}</ref> | Genentech<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = INVIRASE (SAQUINAVIR MESYLATE) CAPSULE INVIRASE (SAQUINAVIR MESYLATE) TABLET, FILM COATED [GENENTECH, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c00d1607-ac36-457b-a34b-75ad74f9cf0a | publisher = | date = | accessdate = }}</ref> | ||
{| | |||
|- | |||
| [[File:|800px|thumb]] | |||
|- | |||
|} | |||
==References== | ==References== | ||
Latest revision as of 17:05, 9 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]
Labels And Packages
=
PRINCIPAL DISPLAY PANEL - 500 mg Bottle Label
NDC 0004-0244-51
Invirase® (saquinavir mesylate) Tablets
500 mg
Each tablet contains saquinavir mesylate equivalent to 500 mg saquinavir (free base).
Rx only
ALERT: Find out about medicines that should NOT be taken with INVIRASE.
Attention Pharmacist: Dispense the attached Medication Guide to each patient. Do not cover ALERT box with pharmacy label.
120 tablets
Genentech
| [[File:|800px|thumb]] |
PRINCIPAL DISPLAY PANEL - 200 mg Bottle Label
NDC 0004-0245-15
Invirase® (saquinavir mesylate) Capsules
200 mg
Each capsule contains saquinavir mesylate equivalent to 200 mg saquinavir (free base).
Rx only
ALERT: Find out about medicines that should NOT be taken with INVIRASE.
Attention Pharmacist: Dispense the attached Medication Guide to each patient. Do not cover ALERT box with pharmacy label.
270 capsules
Genentech[1]
| [[File:|800px|thumb]] |
References
Adapted from the FDA Package Insert.